|
US4013682A
(en)
*
|
1973-08-03 |
1977-03-22 |
Akzona Incorporated |
N-hydroxy-amidine compounds
|
|
NL7315350A
(nl)
*
|
1973-11-09 |
1975-05-13 |
Akzo Nv |
Nieuwe aminoguanidine verbindingen.
|
|
US4101675A
(en)
*
|
1973-11-09 |
1978-07-18 |
Akzona Incorporated |
Novel 2,6-di-substituted phenyl-aminoquanidine containing compositions and methods of using same and pharmaceutical compositions containing the same and therapeutic method
|
|
NL7407469A
(nl)
*
|
1974-06-01 |
1975-12-03 |
Akzo Nv |
Nieuwe amidinohydrazonverbindingen.
|
|
US5312840A
(en)
*
|
1986-07-10 |
1994-05-17 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
|
US5502255A
(en)
*
|
1986-07-10 |
1996-03-26 |
State Of Oregon Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
|
DK0517852T3
(da)
|
1990-03-02 |
2002-10-07 |
Oregon State |
Tri- og tetrasubstituerede guanidinerog disses anvendelse som excitatoriske aminosyre-antagonister
|
|
US5336689A
(en)
*
|
1990-03-02 |
1994-08-09 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
US5262568A
(en)
*
|
1990-03-02 |
1993-11-16 |
State Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
EP0532642A1
(en)
*
|
1990-05-25 |
1993-03-24 |
STATE OF OREGON, acting through OREGON STATE BOARD OF HIGHER EDUCATION, acting for OREGON HEALTH SC. UNIV. AND UNIV. OF OREGON |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
|
US5741661A
(en)
*
|
1991-02-08 |
1998-04-21 |
Cambridge Neuroscience, Inc. |
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
|
|
US5403861A
(en)
*
|
1991-02-08 |
1995-04-04 |
Cambridge Neuroscience, Inc. |
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
|
|
US5847006A
(en)
*
|
1991-02-08 |
1998-12-08 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
KR20030097618A
(ko)
*
|
1993-05-27 |
2003-12-31 |
캠브리지 뉴로사이언스, 인코포레이티드 |
치료용 치환 구아니딘류
|
|
WO1995014461A1
(en)
*
|
1993-11-23 |
1995-06-01 |
Cambridge Neuroscience, Inc. |
Therapeutic substituted guanidines
|
|
US5877218A
(en)
|
1994-01-10 |
1999-03-02 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
HU225986B1
(en)
*
|
1994-01-10 |
2008-02-28 |
Teva Pharma |
Use of 1-aminoindan derivatives for preparing pharmaceutical compns. and 1-aminoindan derivatives
|
|
CA2182302A1
(en)
*
|
1994-02-03 |
1995-08-10 |
Stanley M. Goldin |
Therapeutic guanidines
|
|
US7351743B1
(en)
|
1994-02-03 |
2008-04-01 |
Wyeth |
Therapeutic guanidines
|
|
US6143791A
(en)
*
|
1994-02-03 |
2000-11-07 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
US6787569B1
(en)
|
1994-02-03 |
2004-09-07 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
US6025355A
(en)
*
|
1997-05-19 |
2000-02-15 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
|
US6242198B1
(en)
|
1996-07-25 |
2001-06-05 |
Cambridge Neuroscience, Inc. |
Methods of treatment of eye trauma and disorders
|
|
US6756389B2
(en)
*
|
1996-08-09 |
2004-06-29 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
|
PT966435E
(pt)
|
1996-12-18 |
2005-06-30 |
Yissum Res Dev Co |
Derivados aminoindano
|
|
US6737547B1
(en)
|
1998-12-31 |
2004-05-18 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using N-acyl-1H-aminoindenes
|
|
US20040010038A1
(en)
*
|
2002-02-27 |
2004-01-15 |
Eran Blaugrund |
Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
|
|
US20070135518A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Marta Weinstock-Rosin |
Use of low-dose ladostigil for neuroprotection
|
|
CA2634166C
(en)
*
|
2005-12-09 |
2016-03-29 |
Marta Weinstock-Rosin |
Use of low-dose ladostigil for neuroprotection
|
|
TW200744576A
(en)
*
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|